Case Studies
Drug Constellations
Drug Constellations
Optibrium’s drug constellations provide an instant, visual summary of important small-molecule drugs for a therapeutic class or indication. Ten drugs for each indication are mapped across the ‘chemical space’ of all marketed drugs. A summary of key data is provided for each compound, along with an assessment of its pharmacokinetic properties against a profile of criteria that are relevant to the therapeutic indication.
There are currently two constellations in the series. The first of the constellations depicts the top-ten drugs for cardiovascular indications while the second describes important drugs for neglected diseases.
For each constellation we also provide the detailed data used for each compound, along with references for the sources.
Neglected Diseases
This constellation depicts ten drugs for neglected diseases and a comparison of their key pharmacokinetic properties. If you’d like a high quality printed version of this constellation, please contact us and we will be happy to send you a copy. Alternatively, you can download the neglected disease constellation here.
The detailed data used for each compound in the neglected diseases constellation, along with references for the sources, is available for you here.
Cardiovascular
This constellation depicts the top-ten small molecule cardiovascular drugs by 2015 sales and a comparison of their key pharmacokinetic properties. If you’d like a high quality printed version of this constellation, please contact us and we will be happy to send you a copy. Alternatively, you can download the cardiovascular constellation here.
The detailed data used for each compound, along with references for the sources for the cardiovascular constellation is available here.
